RHOA and cancer: Although the overexpression of RhoA has been frequently recognized in various cancers and was found to be significantly associated with poor prognosis in gastric cancer [10], similar overall survival (OS) rates were nevertheless observed between patients with RHOA mutant and wild-type gastric cancers [11, 12]; therefore, the prognostic value of this gene mutation is poor.